Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of levodopa methyl ester hydrochloride in the preparation of drugs for preventing and treating rheumatoid arthritis

A technology of levodopa methyl hydrochloride and rheumatoid, applied in the field of new drug use, can solve problems such as the relationship between LDME that has not been studied, and achieve the effects of reducing joint damage, taking convenience and reducing symptoms

Inactive Publication Date: 2017-08-25
THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is currently no research on the relationship between LDME and rheumatoid arthritis, from which the present invention derives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of levodopa methyl ester hydrochloride in the preparation of drugs for preventing and treating rheumatoid arthritis
  • Application of levodopa methyl ester hydrochloride in the preparation of drugs for preventing and treating rheumatoid arthritis
  • Application of levodopa methyl ester hydrochloride in the preparation of drugs for preventing and treating rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] 1. Materials and methods

[0033] 1. Materials

[0034] 1.1 Reagents and experimental equipment

[0035] 1.1.1 Main Drugs and Reagents

[0036] Levodopa methyl ester hydrochloride (LDME), dimethyl sulfoxide (DMSO), hydrogen peroxide, ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA) were purchased from Sigma, USA; bovine type II collagen, incomplete IFA and complete Freund's adjuvant (CFA) were purchased from Chondrex, the United States; methanol, hydrochloric acid, glacial acetic acid, ammonia water, absolute ethanol, 95% ethanol, and paraformaldehyde were purchased from Shanghai Feng Chemical Reagent Co., Ltd.; Cole's hematoxylin staining solution (conventional staining) and eosin staining solution were purchased from Beijing Suo Laibao Technology Co., Ltd.; TNF-α, IL-1β, IL-6 enzyme-linked immunosorbent assay kits were purchased from Biosource, the United States.

[0037] 1.1.2 Main Instruments

[0038] Micro-CT (SkyScan 1176, Belgium), paraffin slicer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides application of levodopa methyl ester hydrochloride to preparation of drugs for preventing and treating rheumatoid arthritis. The chemical structural formula of levodopa methyl ester hydrochloride is shown in the description. The levodopa methyl ester hydrochloride provided by the invention has an exact curative effect on rheumatoid arthritis, so that a powerful basis is provided for developing levodopa methyl ester hydrochloride into a new drug.

Description

technical field [0001] The invention belongs to the technical field of new uses of medicines, and relates to the medicinal use of levodopa methyl hydrochloride, in particular to the application of levodopa methyl hydrochloride in the preparation of medicines for preventing and treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis (RA) is a common systemic autoimmune disease characterized by chronic, progressive, and erosive arthritis. It mainly affects small joints such as hands, wrists, and feet, and can also affect Such as heart, lungs, nervous system and other organs or tissues. The basic pathological changes of RA are synovial inflammation, pannus formation, and progressive destruction of articular cartilage and bone. Patients may have joint pain, swelling, stiffness and permanent joint destruction at various stages of the disease process. If not controlled in time, it will eventually lead to joint deformity and loss of function, with a high ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/216A61P29/00A61P19/02
Inventor 耿德春杨惠林徐耀增邵洪国王熠军
Owner THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com